Clinical trials
Phase 2 Brain Neoplasms trials in Denmark
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2018 | 2 |
| 2020 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anders Rosendal Korshøj | 1 |
| Eli Lilly and Company | 1 |
| Inge Marie Svane | 1 |
| Karyopharm Therapeutics Inc | 1 |
| Rigshospitalet, Denmark | 1 |
| Seagen Inc. | 1 |
| Ulrik Lassen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Brain Neoplasms | 7 |
| Glioma | 3 |
| Glioblastoma | 2 |
| Astrocytoma | 1 |
| Breast Neoplasms | 1 |
| Ependymoma | 1 |
| Melanoma | 1 |
| Neoplasms | 1 |
| Oligodendroglioma | 1 |
| Recurrence | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.